DocGo (NASDAQ:DCGO) Given “Buy” Rating at Needham & Company LLC

DocGo (NASDAQ:DCGO)‘s stock had its “buy” rating reiterated by research analysts at Needham & Company LLC in a report released on Tuesday,Benzinga reports. They currently have a $3.00 price target on the stock. Needham & Company LLC’s price objective suggests a potential upside of 361.54% from the stock’s previous close.

Separately, Weiss Ratings reiterated a “sell (d-)” rating on shares of DocGo in a research report on Monday, December 29th. One equities research analyst has rated the stock with a Buy rating, three have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $2.25.

DocGo Stock Down 1.1%

Shares of NASDAQ DCGO opened at $0.65 on Tuesday. The stock has a market capitalization of $63.58 million, a price-to-earnings ratio of -1.25 and a beta of 0.95. DocGo has a 52 week low of $0.60 and a 52 week high of $2.89. The firm has a 50-day moving average price of $0.77 and a 200 day moving average price of $1.03.

Institutional Investors Weigh In On DocGo

Several institutional investors and hedge funds have recently made changes to their positions in the business. P.A.W. Capital Corp grew its stake in DocGo by 60.0% in the 2nd quarter. P.A.W. Capital Corp now owns 3,200,000 shares of the company’s stock valued at $5,024,000 after acquiring an additional 1,200,000 shares during the last quarter. Geode Capital Management LLC raised its position in DocGo by 3.4% during the fourth quarter. Geode Capital Management LLC now owns 2,259,901 shares of the company’s stock worth $1,984,000 after acquiring an additional 73,900 shares during the last quarter. Jefferies Financial Group Inc. raised its position in DocGo by 5.7% during the second quarter. Jefferies Financial Group Inc. now owns 2,144,456 shares of the company’s stock worth $3,367,000 after acquiring an additional 115,000 shares during the last quarter. State Street Corp lifted its holdings in shares of DocGo by 2.0% in the fourth quarter. State Street Corp now owns 1,969,603 shares of the company’s stock valued at $1,729,000 after purchasing an additional 39,125 shares in the last quarter. Finally, Isthmus Partners LLC lifted its holdings in shares of DocGo by 13.8% in the fourth quarter. Isthmus Partners LLC now owns 888,845 shares of the company’s stock valued at $780,000 after purchasing an additional 107,592 shares in the last quarter. 56.44% of the stock is currently owned by hedge funds and other institutional investors.

More DocGo News

Here are the key news stories impacting DocGo this week:

• Positive Sentiment: Management set 2026 revenue guidance of $290M–$310M and reiterated a push toward profitability while saying it is exploring strategic alternatives — a forward-looking plan that can support valuation if execution and margin improvement follow. DocGo outlines 2026 revenue guidance of $290M–$310M as company targets profitability and explores strategic alternatives
• Positive Sentiment: Q4 revenue beat consensus and management raised near-term outlook, which triggered an initial strong intraday rally (reports noted a ~15% jump after results). This revenue upside supports the company’s growth story despite other headwinds. DocGo shares surge 15% on Q4 revenue beat and raised guidance
• Neutral Sentiment: Full Q4 earnings call transcript is available — management provided color on the revenue beat, profitability timeline, and the rationale behind strategic-alternatives exploration; investors should read the transcript for details on cadence and capital allocation. DocGo Inc. (DCGO) Q4 2025 Earnings Call Transcript
• Negative Sentiment: Despite the revenue beat, EPS missed badly — the company reported a sizable per-share loss that was well below estimates, which is keeping investor focus on profitability execution and potential dilution. DocGo Inc. (DCGO) Reports Q4 Loss, Beats Revenue Estimates
• Negative Sentiment: Reported revenue was down year-over-year due to the wind-down of the MIG business, and profitability metrics remain negative (net margin and ROE). Those structural headwinds help explain why some of the initial rally faded as investors dig into the quality of revenue and near-term cash flow. DocGo Announces Fourth Quarter and Full Year 2025 Results

About DocGo

DocGo, Inc is a U.S.-based integrated healthcare company that delivers on-demand and mobile healthcare services. The company’s business model centers on deploying customized medical clinics paired with a digital care platform to bring primary and acute care directly to patients. Through a combination of telemedicine and over-the-road medical units, DocGo addresses routine medical exams, chronic disease management, occupational health screenings, specialist consultations and urgent care interventions.

In addition to its mobile clinic fleet, DocGo’s digital platform offers 24/7 virtual care, facilitating remote consultations via video, phone or secure messaging.